Concepedia

Ganghyuck Lee

GL

Statistics

Publications

4

Citations

146

H-Index

4

Active since

2016

Affiliations

Boehringer Ingelheim (Japan)(Current)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (Philippines)

Ganghyuck Lee is an author at Boehringer Ingelheim (Japan) specializing in pharmacology, pharmacotherapy, and glycemic control.

Publications per year

2016–2018

4

Publications

4

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

Atsutaka Yasui, Ganghyuck Lee, Tetsuaki Hirase et al. · Diabetes Therapy · 2018 · 79 citations · Full text

, , +17

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial

Akira Shimada, Toshiaki Hanafusa, Atsutaka Yasui et al. · Diabetes Obesity and Metabolism · 2018 · 41 citations · Full text

, , +17

Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial

Kohei Kaku, Masakazu Haneda, Yuko Tanaka et al. · Diabetes Obesity and Metabolism · 2018 · 15 citations · Full text

, , +17

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study

Jitsuo Higaki, Issei Komuro, Kosuke Shiki et al. · Hypertension Research · 2016 · 11 citations · Full text

, , +17

1–4 of 4